Health

DPHARM’s 13th Annual Event on Modernizing Clinical Research Announces the 2023 Agenda from the Conference Forum

Leave a comment


In addition to learning about innovations in the clinical trial industry through a diverse spectrum of presentations and exhibitors, I’m eager to take advantage of opportunities to meet and network with colleagues.


NEW YORK (PRWEB)

The Conference Forum announced today the launch of the 13th annual DPHARM: Disruptive Innovations to Modernize Clinical Research conference, taking place September 20-22, 2023 in Boston at the Westin Copley Place.

“DPHARM is the most highly anticipated event of the year for the clinical trials community because it reports on innovation to increase trial access, reduce burden to patient participation, increase efficiencies and reduce time to market,” said Valerie Bowling, Executive Director, Conference Forum.

Senior industry leadership across clinical operations, trial design and digital transformation provide examples of innovations including:

  • Boehringer Ingelheim on their medical excellence journey to achieve holistic evidence generation

  • Merck and Moderna on integrating innovative science & operational excellence to develop individualized neoantigen therapies

  • Eisai on the Bayesian methods that resulted in an accelerated approval in Alzheimer’s Disease

  • Biogen on assessing pandemic-era changes to clinical operations to ensure clinical trial operations are scalable, repeatable and optimized

  • And Operation Warp Speed on the largest, safest, and most rapid vaccine deployment effort in global history

“In addition to learning about innovations in the clinical trial industry through a diverse spectrum of presentations and exhibitors, I’m eager to take advantage of opportunities to meet and network with colleagues,” said Doug Schantz, SVP of Clinical Operations, Asklepios BioPharmaceuticals. “DPHARM also brings the perspective of the patient and from outside the industry, which differentiates it from other conferences.”

Through pharma-led sessions and case studies, the 2023 meeting will take a deep focus on innovations in the following specialized areas:

  • Workflow processes and scalable execution to achieve speed, quality and access

  • Gaps in site workforce capabilities

  • Patient-enabled clinical trial technologies

  • State of innovation in clinical trial technology and methodologies for scalability

  • Digital biomarker development

  • Utilizing data for better protocol designs and trial execution

  • Innovative trial designs

  • Implementing an end-to-end digital transformation strategy

  • Rebuilding trust and loyalty with diverse communities and sites

  • Strategic approaches to AI/ML and ChatGPT

  • Delivering exceptional clinical trial experiences for patients

  • Effective approaches to drive hybrid and DCT model deployment

DPHARM will be preceded by the 10th annual Mobile Tech in Clinical Trials, September 19, 2023. To learn more about the full DPHARM agenda, visit http://www.DPHARMconference.com.

About DPHARM:

DPHARM®: Disruptive Innovations to Modernize Clinical Research offers an unparalleled opportunity to hear senior clinical operation executives and innovative thought leaders unveil the latest innovations to modernize clinical trials and reduce patient burden. The concept of DPHARM was founded by Pfizer and Janssen, who continue to play a key role on the steering committee to deliver a highly relevant and engaging program.

About The Conference Forum:

The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. The company also publishes six newsletters and produces PharmaTalkRadio, virtual events, and webinars.

Share article on social media or email:

Leave a Reply